Universal decolonization of all ICU patients can help reduce bloodstream infections caused by methicillin-resistant Staphylococcus aureus and also lower healthcare costs, and does so better compared ...

SAN FRANCISCO — Hexachlorophene and mupirocin do not effectively remove colonies of methicillin-resistant Staphylococcus aureus (MRSA) from people with HIV, a new study shows. "For several years ...

The three-arm randomized trial was conducted at five hospitals in Pennsylvania with members of 223 households. Participants were split into three groups: those who received only education on personal ...

We use an extended version of a previously described stochastic simulation model. [10] The model contains three hospitals of 693 beds, each with an extramural population of 220,000 subjects. Patients ...

Current decolonization methods for methicillin-resistant Staphylococcus aureus (MRSA) face several challenges, including resistance development or microbiome disruption. Hypharm GmbH has presented ...

The Agency for Healthcare Research and Quality and the Centers for Disease Control and Prevention offer instructions for implementing universal decolonization in adult intensive care units to ...

Aiming to Provide a Novel Solution Against Post-Operative MRSA Infections Demonstrated its Efficacy and Safety through previous Clinical Trials Company seeks global partners to co-develop toward ...

Methicillin-resistant staph infections have entered the community, posing a bigger challenge for health-care providers. The CDC outlines what to do. Methicillin-resistant Staphylococcus aureus (MRSA), ...

An international study has, for the first time, revealed a strong and direct link between the rise of antibiotic-resistant bacteria and universal disinfection procedures applied to patients in ...

Universal decolonization of intensive care unit patients was the most effective method for reducing methicillin-resistant Staphylococcus aureus rates in the intensive care unit, according to a study ...

SEOUL, South Korea and BOSTON, May 13, 2025 /PRNewswire/ -- iNtRON Biotechnology, Inc., a biotechnology company focused on developing innovative endolysin-based new biological drug for superbugs and ...